Cargando…
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice
With the genomic revolution and the era of targeted therapy, prognostic and predictive gene signatures are becoming increasingly important in clinical research. They are expected to assist prognosis assessment and therapeutic decision making. Notwithstanding, an evidence-based approach is needed to...
Autores principales: | Michiels, S., Ternès, N., Rotolo, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178139/ https://www.ncbi.nlm.nih.gov/pubmed/27634691 http://dx.doi.org/10.1093/annonc/mdw307 |
Ejemplares similares
-
Prediction of treatment benefit in high-dimensional cox models via gene signatures in randomized clinical trials
por: Ternès, Nils, et al.
Publicado: (2015) -
Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
por: Ternès, Nils, et al.
Publicado: (2016) -
Statistical controversies in clinical research: long-term follow-up of clinical trials in cancer
por: Cuzick, J.
Publicado: (2015) -
Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials
por: Ternès, Nils, et al.
Publicado: (2017) -
Controversies in Diagnosing Sarcopenia in Cirrhosis—Moving from Research to Clinical Practice
por: Sinclair, Marie
Publicado: (2019)